These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 29513699

  • 1. Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis.
    Schaefer M, Sahin T, Berstecher B.
    PLoS One; 2018; 13(3):e0192758. PubMed ID: 29513699
    [Abstract] [Full Text] [Related]

  • 2. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis.
    Schaefer M, Zimmermann K, Enck P.
    Sci Rep; 2023 May 24; 13(1):8372. PubMed ID: 37225724
    [Abstract] [Full Text] [Related]

  • 4. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.
    J Allergy Clin Immunol; 2000 May 24; 105(5):917-22. PubMed ID: 10808172
    [Abstract] [Full Text] [Related]

  • 5. Effects of a probiotic treatment (Enterococcus faecalis) and open-label placebo on symptoms of allergic rhinitis: study protocol for a randomised controlled trial.
    Schaefer M, Enck P.
    BMJ Open; 2019 Oct 28; 9(10):e031339. PubMed ID: 31662387
    [Abstract] [Full Text] [Related]

  • 6. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
    Nunes C, Ladeira S.
    J Investig Allergol Clin Immunol; 2000 Oct 28; 10(1):20-3. PubMed ID: 10780795
    [Abstract] [Full Text] [Related]

  • 7. Open-Label Placebos Improve Symptoms in Allergic Rhinitis: A Randomized Controlled Trial.
    Schaefer M, Harke R, Denke C.
    Psychother Psychosom; 2016 Oct 28; 85(6):373-374. PubMed ID: 27744433
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial.
    Sun Y, Zhao H, Ye Y, Nie W, Bai W, Liu J, Li S, Wang F, Han M, He L.
    Trials; 2016 Jun 30; 17(1):305. PubMed ID: 27363578
    [Abstract] [Full Text] [Related]

  • 9. A Network Meta-analysis of Randomized Controlled Trials Focusing on Different Allergic Rhinitis Medications.
    Xiao J, Wu WX, Ye YY, Lin WJ, Wang L.
    Am J Ther; 2016 Jun 30; 23(6):e1568-e1578. PubMed ID: 25867532
    [Abstract] [Full Text] [Related]

  • 10. Socheongryong-tang for improving nasal symptoms associated with allergic rhinitis: A study protocol for a randomized, open-label, cetirizine controlled, clinical trial.
    Kim YE, Son MJ, Jung SY, Kwon O, Lee JH, Lee DH.
    Medicine (Baltimore); 2018 Aug 30; 97(34):e11812. PubMed ID: 30142767
    [Abstract] [Full Text] [Related]

  • 11. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
    Day JH, Briscoe MP, Clark RH, Ellis AK, Gervais P.
    Ann Allergy Asthma Immunol; 1997 Aug 30; 79(2):163-72. PubMed ID: 9291422
    [Abstract] [Full Text] [Related]

  • 12. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial.
    Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B.
    Clin Exp Allergy; 2003 Mar 30; 33(3):351-8. PubMed ID: 12614450
    [Abstract] [Full Text] [Related]

  • 13. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis.
    Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM.
    Allergy Asthma Proc; 2014 Mar 30; 35(4):338-45. PubMed ID: 24992553
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J, Mullol J, Valero A, Valiente R, Bilastine Study Group.
    Curr Med Res Opin; 2012 Jan 30; 28(1):121-30. PubMed ID: 22077106
    [Abstract] [Full Text] [Related]

  • 15. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH, Briscoe M, Rafeiro E, Chapman D, Kramer B.
    Ann Allergy Asthma Immunol; 2001 Dec 30; 87(6):474-81. PubMed ID: 11770694
    [Abstract] [Full Text] [Related]

  • 16. Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis.
    Kube T, Hofmann VE, Glombiewski JA, Kirsch I.
    PLoS One; 2021 Dec 30; 16(3):e0248367. PubMed ID: 33705475
    [Abstract] [Full Text] [Related]

  • 17. Quality of life in patients with allergic rhinitis: a clinical trial comparing the use of bilastine versus loratadine.
    Locks RB, Dos Santos K, da Silva J.
    Clin Otolaryngol; 2017 Apr 30; 42(2):218-224. PubMed ID: 27385478
    [Abstract] [Full Text] [Related]

  • 18. The role of patient beliefs in open-label placebo effects.
    Leibowitz KA, Hardebeck EJ, Goyer JP, Crum AJ.
    Health Psychol; 2019 Jul 30; 38(7):613-622. PubMed ID: 31021124
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study.
    Segall N, Gawchik S, Georges G, Haeusler JM.
    Ann Allergy Asthma Immunol; 2010 Mar 30; 104(3):259-67. PubMed ID: 20377116
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May 30; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.